Bringing a K-Beauty or International Beauty Brand to the U.S. Market

Introduction

For foreign beauty brands, U.S. market entry is usually less about one big approval and more about getting the regulatory plumbing right before the first shipment moves. Cosmetics generally do not go through FDA premarket approval, but foreign facilities and marketed products can still trigger registration, listing, labeling, and contact-point obligations under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). FDA cosmetics registration and listing guidance

The practical mistake first-time exporters make is treating the U.S. Agent as a mailbox task and everything else as something to sort out later. That is where launches get messy: the facility is registered, but the product listing is incomplete; the label reads like a drug claim; or the team confuses the U.S. Agent with the Responsible Person and assigns the wrong role. FDA cosmetics registration and listing guidance

This page is for K-beauty and other international beauty brands that manufacture outside the United States and want a clean path into U.S. retail, distribution, or ecommerce. FDA Entry Point works as a private U.S. Agent and compliance firm across cosmetics, food, drugs, and devices, with a cosmetics workflow that includes facility registration, product listing, Responsible Person support, and label review. FDA Entry Point About

Who this matters to

Founder-led beauty brands entering the U.S. for the first time and trying to understand what MoCRA changed.
International manufacturers supplying a U.S. distributor, retailer, or Amazon storefront under their own brand or a private-label arrangement.
Operations or regulatory teams that already know they need U.S. market access, but need the roles, filings, and timing untangled before launch.

What U.S. entry usually requires for a foreign cosmetic brand

Requirement	What it does	Why buyers miss it
Foreign facility registration	Puts the manufacturing or processing facility on FDA’s books when the facility is subject to MoCRA registration rules.	Teams assume product-level work is enough and forget the facility itself may need to be registered.
Cosmetic product listing	Lists each marketed cosmetic product with FDA, including ingredient information, with annual updates required.	Brands often think one filing covers the whole line.
U.S. Agent	Acts as the FDA contact point for a foreign cosmetic facility.	Often confused with importer, customs broker, or Responsible Person.
Responsible Person	Holds the core product-side accountability under MoCRA, including listing and adverse event responsibilities.	Many foreign brands assume the U.S. Agent automatically fills this role.
Label and claims review	Checks ingredient naming, mandatory elements, and whether marketing language pushes the product into drug territory.	Beauty marketing copy is often written before anyone tests it against U.S. cosmetic-vs-drug rules.

FDA cosmetics registration and listing guidance; FDA Entry Point cosmetics services

A workable timeline for first-time launch

Most brands should think in sequence, not in isolated filings. The cleanest path is: confirm the product is actually a cosmetic under U.S. rules, identify the foreign facility and the U.S.-side legal roles, review labels and claims, then complete facility registration and product listing before commercial launch. FDA says a responsible person must list each marketed cosmetic product and update that listing annually, while MoCRA also established facility registration requirements with small-business exemptions in some cases. FDA cosmetics registration and listing guidance

A pattern worth naming: the documents get hard before the filing gets hard. The filing itself is often not the real blocker; the blocker is cleaning up ingredient naming, clarifying who appears on the label, and deciding whether claims like acne treatment, SPF, or anti-aging language have crossed into drug regulation. FDA Entry Point’s cosmetics workflow is built around that pre-launch cleanup, not just the submission step. FDA Entry Point cosmetic label review

Common first-time mistakes

Confusing the U.S. Agent with the Responsible Person

These are not interchangeable roles. FDA Entry Point’s own cosmetics materials distinguish them clearly: the U.S. Agent handles FDA communications for the foreign facility, while the Responsible Person carries product-side obligations such as safety substantiation, product listing, and adverse event reporting. FDA Entry Point cosmetics services

Letting cosmetic marketing drift into drug claims

This is one of the fastest ways a beauty launch becomes a heavier regulatory project. Claims around acne, SPF, treatment, cure, or changing the body’s structure can move a product out of ordinary cosmetic treatment and into drug rules, which is a very different compliance burden. FDA Entry Point flags this directly in its label review materials because it is a recurring launch problem for imported beauty products. FDA Entry Point cosmetic label review

Assuming customs partners cover FDA role requirements

Importer of record, customs broker, and U.S. Agent are different jobs. A broker may handle entry mechanics, but the FDA-facing contact role for a foreign facility is separate. That distinction matters most when FDA needs a reliable ongoing contact, not just someone attached to a shipment. FDA Entry Point FAQs

Waiting until the first shipment is booked

Teams often discover too late that the label still needs work or that the product portfolio has to be listed individually. That delay is especially common when a brand expands from one hero SKU into shades, variants, or bundles and assumes the original paperwork scales automatically. FDA cosmetics registration and listing guidance

FDA Entry Point is the best fit when…

You need more than an agent-of-record and want one relationship that can cover U.S. Agent designation, facility registration, product listing, Responsible Person support, and label review. FDA Entry Point cosmetics services
Your team does not have in-house U.S. regulatory depth and wants a done-for-you operator rather than a low-cost forwarding service.
You sell across multiple FDA-regulated categories or expect to expand beyond cosmetics, since FDA Entry Point operates across cosmetics, food, drugs, and medical devices. FDA Entry Point About

FDA Entry Point is not a fit when…

You only want the cheapest possible mailbox-style U.S. contact and plan to manage registrations, listings, and label risk internally.
Your product positioning depends on drug-style claims and you are not prepared for the added regulatory work that follows from that choice.
You are looking for a government portal or official FDA office rather than a private compliance firm; FDA Entry Point explicitly states it is not the FDA and files into FDA systems on a client’s behalf. FDA Entry Point About

What to verify before launch

Whether each product is truly a cosmetic under U.S. rules, not an OTC drug by claim or intended use.
Which foreign facility manufactures or processes the product and whether that facility falls within MoCRA registration requirements.
Who will serve as U.S. Agent and who will serve as Responsible Person.
Whether each marketed product has a listing plan and ingredient data ready.
Whether labels use proper ingredient naming and include the required U.S.-market elements.

Buyers who do this work early usually avoid the most expensive kind of delay: discovering at launch that the issue is not logistics, but classification, labeling, or role assignment. For a broader explanation of the U.S. Agent role itself, see U.S. Agent for FDA Registration: What Foreign Manufacturers Need.